COVIVIO HOTELS SACA (COVH.PA) Stock Fundamental Analysis

Europe • Euronext Paris • EPA:COVH • FR0000060303

23.3 EUR
-0.1 (-0.43%)
Last: Feb 3, 2026, 05:28 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to COVH. COVH was compared to 42 industry peers in the Diversified REITs industry. Both the profitability and the financial health of COVH get a neutral evaluation. Nothing too spectacular is happening here. While showing a medium growth rate, COVH is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year COVH was profitable.
  • COVH had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: COVH reported negative net income in multiple years.
  • Each year in the past 5 years COVH had a positive operating cash flow.
COVH.PA Yearly Net Income VS EBIT VS OCF VS FCFCOVH.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

  • With a decent Return On Assets value of 2.88%, COVH is doing good in the industry, outperforming 61.90% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 5.87%, COVH is in the better half of the industry, outperforming 64.29% of the companies in the same industry.
  • COVH has a Return On Invested Capital of 3.67%. This is comparable to the rest of the industry: COVH outperforms 59.52% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for COVH is in line with the industry average of 3.37%.
Industry RankSector Rank
ROA 2.88%
ROE 5.87%
ROIC 3.67%
ROA(3y)3.26%
ROA(5y)1.11%
ROE(3y)6.53%
ROE(5y)1.93%
ROIC(3y)3.85%
ROIC(5y)2.91%
COVH.PA Yearly ROA, ROE, ROICCOVH.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

  • COVH has a better Profit Margin (78.86%) than 88.10% of its industry peers.
  • COVH's Profit Margin has declined in the last couple of years.
  • COVH's Operating Margin of 101.41% is amongst the best of the industry. COVH outperforms 97.62% of its industry peers.
  • In the last couple of years the Operating Margin of COVH has remained more or less at the same level.
Industry RankSector Rank
OM 101.41%
PM (TTM) 78.86%
GM N/A
OM growth 3Y10.91%
OM growth 5Y0%
PM growth 3Y43.44%
PM growth 5Y-10.66%
GM growth 3YN/A
GM growth 5YN/A
COVH.PA Yearly Profit, Operating, Gross MarginsCOVH.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

More info and screens

4

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so COVH is destroying value.
  • Compared to 1 year ago, COVH has about the same amount of shares outstanding.
  • COVH has more shares outstanding than it did 5 years ago.
  • COVH has a worse debt/assets ratio than last year.
COVH.PA Yearly Shares OutstandingCOVH.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
COVH.PA Yearly Total Debt VS Total AssetsCOVH.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • COVH has an Altman-Z score of 1.03. This is a bad value and indicates that COVH is not financially healthy and even has some risk of bankruptcy.
  • With a decent Altman-Z score value of 1.03, COVH is doing good in the industry, outperforming 69.05% of the companies in the same industry.
  • COVH has a debt to FCF ratio of 12.71. This is a negative value and a sign of low solvency as COVH would need 12.71 years to pay back of all of its debts.
  • COVH's Debt to FCF ratio of 12.71 is in line compared to the rest of the industry. COVH outperforms 54.76% of its industry peers.
  • A Debt/Equity ratio of 0.70 indicates that COVH is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.70, COVH is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 12.71
Altman-Z 1.03
ROIC/WACC0.68
WACC5.43%
COVH.PA Yearly LT Debt VS Equity VS FCFCOVH.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 1.16 indicates that COVH should not have too much problems paying its short term obligations.
  • COVH has a better Current ratio (1.16) than 85.71% of its industry peers.
  • A Quick Ratio of 1.16 indicates that COVH should not have too much problems paying its short term obligations.
  • COVH's Quick ratio of 1.16 is amongst the best of the industry. COVH outperforms 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.16
COVH.PA Yearly Current Assets VS Current LiabilitesCOVH.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

4

3. Growth

3.1 Past

  • COVH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 242.64%, which is quite impressive.
  • Measured over the past years, COVH shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -12.16% on average per year.
  • The Revenue has decreased by -5.26% in the past year.
  • The Revenue has been growing slightly by 2.29% on average over the past years.
EPS 1Y (TTM)242.64%
EPS 3Y62.03%
EPS 5Y-12.16%
EPS Q2Q%-15.59%
Revenue 1Y (TTM)-5.26%
Revenue growth 3Y14.81%
Revenue growth 5Y2.29%
Sales Q2Q%-12.96%

3.2 Future

  • COVH is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.90% yearly.
  • The Revenue is expected to grow by 0.55% on average over the next years.
EPS Next Y3.01%
EPS Next 2Y0.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.19%
Revenue Next 2Y0.55%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
COVH.PA Yearly Revenue VS EstimatesCOVH.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M 250M
COVH.PA Yearly EPS VS EstimatesCOVH.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0.5 1 1.5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 16.88, COVH is valued correctly.
  • COVH's Price/Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Earnings ratio is at 28.41. COVH is valued slightly cheaper when compared to this.
  • With a Price/Forward Earnings ratio of 13.52, COVH is valued correctly.
  • The rest of the industry has a similar Price/Forward Earnings ratio as COVH.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 25.64, COVH is valued a bit cheaper.
Industry RankSector Rank
PE 16.88
Fwd PE 13.52
COVH.PA Price Earnings VS Forward Price EarningsCOVH.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 61.90% of the companies in the same industry are more expensive than COVH, based on the Enterprise Value to EBITDA ratio.
  • COVH's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. COVH is more expensive than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.91
EV/EBITDA 17.07
COVH.PA Per share dataCOVH.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates COVH does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)5.61
PEG (5Y)N/A
EPS Next 2Y0.9%
EPS Next 3YN/A

More info and screens

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 6.41%, COVH is a good candidate for dividend investing.
  • COVH's Dividend Yield is a higher than the industry average which is at 5.30.
  • Compared to an average S&P500 Dividend Yield of 1.83, COVH pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.41%

5.2 History

  • The dividend of COVH decreases each year by -3.01%.
Dividend Growth(5Y)-3.01%
Div Incr Years4
Div Non Decr Years4
COVH.PA Yearly Dividends per shareCOVH.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

  • COVH pays out 19.17% of its income as dividend. This is a sustainable payout ratio.
DP19.17%
EPS Next 2Y0.9%
EPS Next 3YN/A
COVH.PA Yearly Income VS Free CF VS DividendCOVH.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M
COVH.PA Dividend Payout.COVH.PA Dividend Payout, showing the Payout Ratio.COVH.PA Dividend Payout.PayoutRetained Earnings

More info and screens

COVIVIO HOTELS SACA

EPA:COVH (2/3/2026, 5:28:09 PM)

23.3

-0.1 (-0.43%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)10-22
Earnings (Next)02-16
Inst Owners31.31%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap3.68B
Revenue(TTM)260.60M
Net Income(TTM)205.50M
Analysts82.86
Price Target18.67 (-19.87%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.41%
Yearly Dividend1.3
Dividend Growth(5Y)-3.01%
DP19.17%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 16.88
Fwd PE 13.52
P/S 14.13
P/FCF 15.91
P/OCF 10.06
P/B 1.05
P/tB 1.16
EV/EBITDA 17.07
EPS(TTM)1.38
EY5.92%
EPS(NY)1.72
Fwd EY7.4%
FCF(TTM)1.46
FCFY6.29%
OCF(TTM)2.32
OCFY9.94%
SpS1.65
BVpS22.14
TBVpS20.08
PEG (NY)5.61
PEG (5Y)N/A
Graham Number26.22
Profitability
Industry RankSector Rank
ROA 2.88%
ROE 5.87%
ROCE 4.15%
ROIC 3.67%
ROICexc 4.06%
ROICexgc 4.3%
OM 101.41%
PM (TTM) 78.86%
GM N/A
FCFM 88.79%
ROA(3y)3.26%
ROA(5y)1.11%
ROE(3y)6.53%
ROE(5y)1.93%
ROIC(3y)3.85%
ROIC(5y)2.91%
ROICexc(3y)4.03%
ROICexc(5y)3.03%
ROICexgc(3y)4.17%
ROICexgc(5y)3.12%
ROCE(3y)4.35%
ROCE(5y)3.29%
ROICexgc growth 3Y33.75%
ROICexgc growth 5Y5.13%
ROICexc growth 3Y32.01%
ROICexc growth 5Y4.39%
OM growth 3Y10.91%
OM growth 5Y0%
PM growth 3Y43.44%
PM growth 5Y-10.66%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 12.71
Debt/EBITDA 6.96
Cap/Depr 151.01%
Cap/Sales 51.57%
Interest Coverage 4.11
Cash Conversion 103.55%
Profit Quality 112.6%
Current Ratio 1.16
Quick Ratio 1.16
Altman-Z 1.03
F-Score5
WACC5.43%
ROIC/WACC0.68
Cap/Depr(3y)165.18%
Cap/Depr(5y)147.82%
Cap/Sales(3y)30.61%
Cap/Sales(5y)33.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)242.64%
EPS 3Y62.03%
EPS 5Y-12.16%
EPS Q2Q%-15.59%
EPS Next Y3.01%
EPS Next 2Y0.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.26%
Revenue growth 3Y14.81%
Revenue growth 5Y2.29%
Sales Q2Q%-12.96%
Revenue Next Year-1.19%
Revenue Next 2Y0.55%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8.66%
EBIT growth 3Y27.34%
EBIT growth 5Y2.29%
EBIT Next Year-17.92%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-7.4%
FCF growth 3Y35.97%
FCF growth 5Y2.55%
OCF growth 1Y24.44%
OCF growth 3Y30.01%
OCF growth 5Y4.76%

COVIVIO HOTELS SACA / COVH.PA FAQ

What is the fundamental rating for COVH stock?

ChartMill assigns a fundamental rating of 4 / 10 to COVH.PA.


What is the valuation status of COVIVIO HOTELS SACA (COVH.PA) stock?

ChartMill assigns a valuation rating of 3 / 10 to COVIVIO HOTELS SACA (COVH.PA). This can be considered as Overvalued.


How profitable is COVIVIO HOTELS SACA (COVH.PA) stock?

COVIVIO HOTELS SACA (COVH.PA) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for COVH stock?

The Price/Earnings (PE) ratio for COVIVIO HOTELS SACA (COVH.PA) is 16.88 and the Price/Book (PB) ratio is 1.05.


Can you provide the expected EPS growth for COVH stock?

The Earnings per Share (EPS) of COVIVIO HOTELS SACA (COVH.PA) is expected to grow by 3.01% in the next year.